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Intrathymic T-cell differentiation is under the control of the thymic microenvironment, which acts
on maturing thymocytes via membrane as well as soluble products. Increasing data show that this
process can be modulated by classical hormones, as exemplified herein by prolactin (PRL) and
growth hormone (GH), largely secreted by the pituitary gland.
Both PRL and GH stimulate the secretion of thymulin, a thymic hormone produced by thymic
epithelial cells. Conversely, low levels of circulating thymulin parallel hypopituitary states.
Interestingly, the enhancing effects of GH on thymulin seem to be mediated by insulinlike growth
factor (IGF-1) since they can be abrogated with anti-IGF-1 or anti-IGF-l-receptor antibodies.
The influence of PRL and GH on the thymic epithelium is pleiotropic: PRL enhances in vivo the
expression of high-molecular-weight cytokeratins and stimulates in vitro TEC proliferation, an effect
that is shared by GH and IGF-1.
Differentiating T cells are also targets for the intrathymic action of PRL and GH. In vivo inoculation
of a rat pituitary cell line into old rats results in restoration of the thymus, including differentiation
of CD4-CD8- thymocytes into CD4+CD8 cells. Furthermore, PRL may regulate the maintenance
of thymocyte viability during the double-positive stage of thymocyte differentiation.
Injections of GH into aging mice increase total thymocyte numbers and the percentage of CD3-
bearing cells, as well as the Concanavalin-A mitogenic response and IL-6 production by thymocytes.
Interestingly, similar findings are observed in animals treated with IGF-1. Lastly, the thymic
hypoplasia observed in dwarf mice can be reversed with GH treatment.
In keeping with the data summarized earlier is the detection of receptors for PRL and GH on both
thymocytes and thymic epithelial cells. Importantly, recent studies indicate that both cell types
can produce PRL and GH intrathymically. Similarly, production of IGF-1 and expression of a
corresponding receptor has also been demonstrated.
In conclusion, these data strongly indicate that the thymus is physiologically under control of
pituitary hormones PRL and GH. In addition to the classical endocrine pathway, paracrine and
autocrine circuits are probably implicated in such control.
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INTRODUCTION
Bone-marrow-derived prothymocytes migrate into the
thymus where they undergo a complex process of
differentiation, largely dependent on interactions with
the thymic microenvironment, a tridimensional cellu-
lar network formed by epithelial cells, macrophages,
dendritic cells, and fibroblasts (reviewed by van
Ewijk, 1991; Boyd et al., 1993). Such interactions are
transient, involving sessile elements such as micro-
environmental cells, and migrating components, the
differentiating thymocytes. Along with migration and
differentiation, most thymocytes are negatively
selected (the majority being deleted by apoptosis),
whereas some appear to be positively selected,
rescued from death, eventually yielding the vast
majority of the so-called T-cell repertoire. One key
cellular interaction defining positive or negative
selection involves the TCR/CD3 complex expressed
by differentiating thymocytes with class I or class II
products of the major histocompatibility complex
(MHC) present on the microenvironmental cell mem-
branes, associated with the endogenous peptide to be
recognized (Ashton-Rickardt and Tonegawa, 1994).
In addition, the thymic microenvironment influ-
ences thymocyte migration/differentiation via other
types of interactions. For example, thymic epithelial
cells (TECs) release soluble polypeptides such as
thymic hormones and various cytokines (see reviews
by Safieh-Garabedian et al., 1992; Kendall and
Stebbings, 1994; Boyd et al., 1993) that can modulate
thymocyte behavior. In this respect, thymulin, one
chemically defined thymic hormone is able to induce
the expression of CD90--the Thy-1 marker--(see
review by Bach, 1983) that has been defined as an
adhesion molecule able to transduce signals for the
intrathymic production of cytokines during thymocyte
differentiation (Tentori et al. 1988; He et al., 1991). In
addition to other immune functions (see reviews by
Bach, 1983; Safieh-Garabedian et al., 1992), thymulin
acts on neuroendocrine circuits, modulating the
secretion of various hypothalamic and pituitary hor-
mones (see reviews by Dardenne and Savino, 1996).
Lastly, TEC/thymocyte interactions can also be
mediated via classical adhesion molecules as well as
extracellular matrix (ECM) ligands and receptors
(reviewed by Patel and Haynes, 1993; Savino et al.,
1993).
A further important concept concerns the influence
of extrinsic factors (endogenous and exogenous) on
the thymic microenvironment. In particular, recent
studies point to a neuroendocrine control of the
thymus (see review by Dardenne and Savino, 1994).
In this respect, we will discuss herein the effects of
prolactin (PRL) and growth hormone (GH) on various
aspects of the thymic microenvironment and T-cell
differentiation. Moreover, the intrathymic production
of these hormones as well as the expression of
corresponding receptors by thymic cells will be
analyzed, in an attempt to provide a molecular basis
for autocrine, paracrine, and endocrine pathways that
may be involved in the action of both PRL and GH on
thymus physiology.
THYMIC ENDOCRINE FUNCTION IS
INFLUENCED BY PITUITARY HORMONE
STATUS
The first demonstration that pituitary hormones can
modulate endocrine function came from studies in
dwarf mice that exhibit a precocious age-dependent
decay of thymulin serum levels (Pelletier et al., 1976).
In keeping with this finding, low thymulin levels are
found in hypophysectomized rats and dwarf humans
(see reviews by Dardenne and Savino, 1990, 1992;
Mocheggiani et al., 1994). Conversely, adenopituitary
hyperactivity states, including prolactinoma and acro-
megaly, are paralleled by increased levels of serum
thymulin (Timsit et al., 1989, 1992). Additionally, in
vivo injections ofPRL or GH in respectively young or
old mice and rats, enhance thymulin secretion (Dard-
enne et al., 1989; Goya et al., 1992). Lastly, both
hormones stimulate thymulin secretion by cultured
TEC (Dardenne et al., 1989; Timsit et al., 1992).
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secretion appears to be mediated by insulinlike
growth factor (IGF-1) since GH-induced stim-
ulatory effects can be prevented in vitro by treating
TEC cultures with antibodies specific for IGF-1 or
IGF-1 receptor (Timsit et al., 1992). Accordingly,
IGF-1 alone stimulates thymulin production by cul-
tured TEC. Moreover, there is a positive correlation
between serum levels of thymulin and IGF-1 in
acromegalic patients (Timsit et al., 1992).
PITUITARY HORMONES
PLEIOTROPICALLY INFLUENCE THE
THYMIC EPITHELIUM
In addition to the influence of PRL and GH on thymic
endocrine function, other aspects of TEC physiology
can be modulated by these hormones, thus character-
izing their pleiotropic action on the thymic epi-
thelium. For example, PRL is able to enhance in vivo
the expression of high-molecular-weight cytokeratins
that are restrictly found in the medulla of thymic
lobules (Dardenne et al., 1989). Additionally, PRL
stimulates in vitro TEC proliferation (Dardenne et al.,
1989), an effect that is shared by GH and IGF-1
(Timsit et al., 1992). More recently, augmentation of
ECM expression was seen, not only in cultures of
TEC lines, but also in primary cultures of epithelial
cells derived from isolation of thymic nurse lymphoe-
pithelial complexes (de Mello-Coelho et al., 1997).
Together, these data point to the notion that both PRL
and GH can modulate genes committed to distinct
biological activities of the thymic epithelium.
CONTROL OF THYMOCYTE
DIFFERENTIATION BY PROLACTIN AND
GROWTH HORMONE
In addit!.)n to the effects on microenvironmental cells,
differentiating T cells are targets for the intrathymic
action of PRL and GH. In this respect, it is striking
that in vivo inoculation of GH3 cells (a rat pituitary
cell line able to produce GH and PRL) into old rats
results in restoration of the thymus to the histological
pattern found in young animals (Kelley et al., 1986).
Moreover, in old animals, this procedure promotes
differentiation of CD4-CD8- thymocytes into
CD4+CD8 cells (Li et al., 1992). Furthermore, a
decrease of double-positive cells was demonstrated,
associated with a diminution of thymocyte viability in
cell suspensions of neonatal thymuses treated with
anti-mouse PRL antibodies, able to neutralize exo-
genous PRL. In this study, an increase in
CD4-CD8-CD25 cells was observed, suggesting
that PRL may regulate the maintenance of thymocyte
viability during the double-positive stage of thymo-
cyte differentiation, and could be a relevant signal to
rescue double-positive cells from apoptosis (Gaufo
and Diamond, 1996). Accordingly, an antiapoptotic
effect of this hormone was demonstrated on the Nb2
rat thymic lymphoma cell line (La Voie and Witorsch,
1995). Interestingly, it was shown that PRL induces
the gene expression of cyclins D2 and D3 that
regulate the beginning of Nb2 cell proliferation
(Hosokawa et al., 1994). Lastly, the possibility that
PRL influences the shaping of T-cell repertoire is
suggested, since it can switch the expression of TCR
chains in Nb2 cells (Hosokawa et al., 1996).
A series of in vivo experiments also evidenced
significant changes in thymocyte differentiation under
GH influence. Injections of this hormone into aging
mice increase total thymocyte numbers and the
percentage of CD3-bearing cells (Knyszynski et al.,
1992). In addition, Con-A mitogenic response as well
as IL-6 production by thymocytes are enhanced in
GH-treated aging animals (Goya et al., 1992). Inter-
estingly, cyclosporin-A-induced thymic atrophy is
restored by in vivo treatment with recombinant GH or
IGF- 1 (Beschorner et al., 1991). Lastly, IGF- 1 is able
to induce repopulation of the atrophic thymus from
diabetic rats and mice (Binz et al., 1990; Bergerot et
al., 1995).
The role of GH on thymus development is also
stressed by the findings obtained with GH-deficient
dwarf mice. In these animals, besides the precocious
decline in thymulin serum values (Pelletier et al.,
1976), there is a progressive thymic hypoplasia with
decreased numbers of CD4/8 double-positive thymo-
cytes. Iraportantly, such defects can be largely320 VALIRIA DE MELLO-COELHO et al.
restored by long treatment with GH (Murphy et al.,
1992). It is clear from the data discussed before that a
variety of intrathymic changes take place following
PRL or GH stimulation, further characterizing the
pleiotropic role of these hormones on the thymus.
EXPRESSION OF PROLACTIN AND
GROWTH HORMONE RECEPTORS IN THE
THYMUS
To bring further support to the data obtained in both
experimental models and humans evidencing a role of
PRL and GH on thymus physiology, it was obviously
necessary to demonstrate receptors for such mole-
cules on thymic cells. Both PRL and GH receptors
belong to the haematopoietin-receptor family (that
also includes receptors for various cytokines), which
appears to be derived from a common ancestral gene
that underwent multiple duplications and modifica-
tions (see review by Finidori and Kelly, 1995).
With regard to the PRL receptor, two main forms
have been characterized in murine tissues, probably
resulting from alternative splicing of a primary
transcript (reviewed by Kelly et al., 1993). Both forms
of the receptor were reported in thymic epithelial cells
and differentiating thymocytes, as ascertained by
distinct methodological approaches (Dardenne et al.,
1991; Gagnerault et al., 1993; Nagano and Kelly,
1994; Gunes and Mastro, 1996). Additionally, anti-
PRL receptor antibodies can act as agonists of the
natural ligand, thus mimicking PRL in enhancing
TEC proliferation and thymulin secretion (Dardenne
et al., 1991). It is also noteworthy that the Con-
canavalin-A-induced mitogenic response of thymo-
cytes is paralleled by an augmentation of PRL
receptor density on thymocyte membranes, suggest-
ing that PRL may be related to intrathymic T-cell
activation (Gagnerault et al., 1993). Together, these
data indicate that PRL receptors in thymic cells are
functional.
Intrathymic expression of GH receptor has been
demonstrated by different methodological
approaches. In cultured thymic epithelial cells, such
expression was demonstrated by direct ligand binding
and further Scatchard analysis (Ban et al., 1991).
Also, in situ hybridization studies revealed a positive
signal for GH receptor throughout the thymic cortex
as well as medullary TEC (Mertani et al., 1995). More
recently, this finding was confirmed using cyto-
fluorimetry and RT-PCR (manuscript in preparation).
Expression of GH receptor has been demonstrated in
thymocytes as well. By using biotinylated GH in
tricolor cytofluorimetric studies performed in short-
term cultured murine thymocytes, the GH receptor
was detected in 20-30% of murine thymocytes,
comprising distinct differentiation stages, namely, the
immature CD4-CD8- and CD4+CD8 cells, as well
as single-positive thymocytes for either CD4 or CD8
marker (Gagnerault et al., 1996). Interestingly, the
percentages of GH receptor-bearing thymocytes were
transiently increased after Con-A-induced activation.
INTRATHYMIC PRODUCTION OF
PROLACTIN AND GROWTH HORMONE
Extrapituitary sources of PRL and GH have been
demonstrated in a variety of tissues, including cells of
the immune system (see review by Weigent, 1996).
Intrathymically, PRL expression was detected at the
mRNA transcript level (Touraine et al., 1994; Wu et
al., 1996a), and distinct PRL isoforms were seen in
Con-A-stimulated murine and human thymocytes
(Montgomery et al., 1990, 1992). Interestingly, recent
in situ hybridization studies revealed PRL mRNA in
thymocytes and to a lesser extent in epithelial cells
(Wu et al., 1996a).
Growth hormone production has also been evi-
denced in TEC, as ascertained by in situ hybridization
and immunocytochemistry (Maggiano et al., 1994). In
this study, it was suggested that only a proportion of
TEC would be able to constitutively produce GH. By
contrast, in a recent study in which the intrathymic
production of GH was ascertained by RT-PCR and in
situ hybridization, a positive signal for GH mRNA
was detected in microenvironmental cells and thymo-
cytes (Wu et al., 1996b). Accordingly, GH release
was detected in TEC as well as in thymocyte cultures
(unpublished), thus supporting the hypothesis that322 VALIRIA DE MELLO-COELHO et al.
Thus, in addition to the classical endocrine pathway,
paracrine and autocrine circuits are probably impli-
cated in the PRL/GH control of thymus physiology, as
proposed in Fig. 1. Dissecting such hypothetical
intrathymic circuitry will be certainly relevant for a
better understanding of how the organ functions in
daily life.
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